ESR1 |
Ishikawa (endometrial adenocarcinoma) |
1 h with 10 nM Estradiol (Myers) |
Permissive
Robust
|
Homo sapiens |
ENCSR000BIY
|
MA0112.3
|
ESR1 |
T47D (invasive ductal carcinoma) |
1 h with 100 nM Genistein (Myers) |
Permissive
Robust
|
Homo sapiens |
ENCSR000BJS
|
MA0112.3
|
ESR1 |
T47D (invasive ductal carcinoma) |
1 h with 10 nM Estradiol (Myers) |
Permissive
Robust
|
Homo sapiens |
ENCSR000BKN
|
MA0112.3
|
ESR1 |
T47D (invasive ductal carcinoma) |
1 h with 0.02% Dimethyl sufloxide (DMSO) (Myers) |
Permissive
Robust
|
Homo sapiens |
ENCSR000BLL
|
MA0112.3
|
ESR1 |
T47D (invasive ductal carcinoma) |
100nM bisphenol A (CHEBI:33216) for 30 minute |
Permissive
Robust
|
Homo sapiens |
ENCSR000BQD
|
MA0112.3
|
ESR1 |
Ishikawa (endometrial adenocarcinoma) |
1 h with 100 nM Bisphenol A (Myers) |
Permissive
|
Homo sapiens |
ENCSR000BQR
|
MA0112.3
|
ESR1 |
MCF7 (Invasive ductal breast carcinoma) |
hormone starved for 3 days, treated with 1% ethanol for 45 minutes |
Permissive
Robust
|
Homo sapiens |
GSE19013
...
|
MA0112.3
|
ESR1 |
MCF7 (Invasive ductal breast carcinoma) |
hormone starved for 3 days, treated with 10 nM β-estradiol for 45 minutes |
Permissive
Robust
|
Homo sapiens |
GSE19013
...
|
MA0112.3
|
ESR1 |
MCF7 (Invasive ductal breast carcinoma) |
E2 |
Permissive
Robust
|
Homo sapiens |
GSE26083
...
|
MA0112.3
|
ESR1 |
MCF7 (Invasive ductal breast carcinoma) |
Estrogen |
Permissive
Robust
|
Homo sapiens |
GSE24166
...
|
MA0112.3
|
ESR1 |
MCF7 (Invasive ductal breast carcinoma) |
ETOH (ethanol) |
Permissive
Robust
|
Homo sapiens |
GSE23893
...
|
MA0112.3
|
ESR1 |
MCF7 (Invasive ductal breast carcinoma) |
E2 |
Permissive
Robust
|
Homo sapiens |
GSE23893
...
|
MA0112.3
|
ESR1 |
T47D (invasive ductal carcinoma) |
ETOH (ethanol) |
Permissive
Robust
|
Homo sapiens |
GSE23893
...
|
MA0112.3
|
ESR1 |
T47D (invasive ductal carcinoma) |
ETOH (ethanol) |
Permissive
Robust
|
Homo sapiens |
GSE23893
...
|
MA0112.3
|
ESR1 |
Ishikawa (endometrial adenocarcinoma) |
E2 |
Permissive
|
Homo sapiens |
GSE23893
...
|
MA0112.3
|
ESR1 |
Ishikawa (endometrial adenocarcinoma) |
E2 |
Permissive
Robust
|
Homo sapiens |
GSE23893
...
|
MA0112.3
|
ESR1 |
ECC-1 (endometrial adenocarcinoma) |
ETOH (ethanol) |
Permissive
|
Homo sapiens |
GSE23893
...
|
MA0112.3
|
ESR1 |
ECC-1 (endometrial adenocarcinoma) |
E2 |
Permissive
Robust
|
Homo sapiens |
GSE23893
...
|
MA0112.3
|
ESR1 |
H3396 (breast carcinoma) |
E2 |
Permissive
Robust
|
Homo sapiens |
GSE32332
...
|
MA0112.3
|
ESR1 |
H3396 (breast carcinoma) |
E2 |
Permissive
|
Homo sapiens |
GSE32332
...
|
MA0112.3
|
ESR1 |
H3396 (breast carcinoma) |
E2 |
Permissive
|
Homo sapiens |
GSE32332
...
|
MA0112.3
|
ESR1 |
H3396 (breast carcinoma) |
E2 |
Permissive
Robust
|
Homo sapiens |
GSE32332
...
|
MA0112.3
|
ESR1 |
MCF7 (Invasive ductal breast carcinoma) |
oestrogen |
Permissive
Robust
|
Homo sapiens |
GSE25021
...
|
MA0112.3
|
ESR1 |
MCF7 (Invasive ductal breast carcinoma) |
vehicle |
Permissive
Robust
|
Homo sapiens |
GSE25021
...
|
MA0112.3
|
ESR1 |
uterus |
vehicle |
Permissive
Robust
|
Mus musculus |
GSE36455
...
|
MA0112.3
|
ESR1 |
uterus |
estradiol |
Permissive
Robust
|
Mus musculus |
GSE36455
...
|
MA0112.3
|
ESR1 |
mammary cells |
untreated |
Permissive
|
Mus musculus |
GSE46123
...
|
MA0112.3
|
ESR1 |
mammary cells |
Dexamethasone for 30 minutes |
Permissive
|
Mus musculus |
GSE46123
...
|
MA0112.3
|
ESR1 |
mammary cells |
Estradiol for 30 minutes |
Permissive
Robust
|
Mus musculus |
GSE46123
...
|
MA0112.3
|
ESR1 |
mammary cells |
Dexamethasone + Estradiol for 30 minutes |
Permissive
Robust
|
Mus musculus |
GSE46123
...
|
MA0112.3
|
ESR1 |
mammary cells |
Estradiol for 30 minutes |
Permissive
Robust
|
Mus musculus |
GSE46123
...
|
MA0112.3
|
ESR1 |
mammary cells |
Dexamethasone + Estradiol for 30 minutes |
Permissive
Robust
|
Mus musculus |
GSE46123
...
|
MA0112.3
|
ESR1 |
7438 (mammary carcinoma) |
untreated |
Permissive
Robust
|
Mus musculus |
GSE46123
...
|
MA0112.3
|
ESR1 |
7438 (mammary carcinoma) |
Estradiol for 30 minutes |
Permissive
Robust
|
Mus musculus |
GSE46123
...
|
MA0112.3
|
ESR1 |
7438 (mammary carcinoma) |
Dexamethasone + Estradiol for 30 minutes |
Permissive
Robust
|
Mus musculus |
GSE46123
...
|
MA0112.3
|
ESR1 |
aortic cells |
10 nM beta-estradiol (E2) |
Permissive
|
Mus musculus |
GSE52351
...
|
MA0112.3
|
ESR1 |
liver |
10 nM beta-estradiol (E2) |
Permissive
Robust
|
Mus musculus |
GSE52351
...
|
MA0112.3
|
ESR1 |
liver |
10 nM beta-estradiol (E2) |
Permissive
Robust
|
Mus musculus |
GSE52351
...
|
MA0112.3
|
ESR1 |
uterine cells |
saline vehicle |
Permissive
|
Mus musculus |
GSE56466
...
|
MA0112.3
|
ESR1 |
MCF7 (Invasive ductal breast carcinoma) |
none |
Permissive
|
Homo sapiens |
GSE60517
...
|
MA0112.3
|
ESR1 |
MCF7 (Invasive ductal breast carcinoma) |
none |
Permissive
|
Homo sapiens |
GSE60517
...
|
MA0112.3
|
ESR1 |
LTED (breast cancer) |
none |
Permissive
Robust
|
Homo sapiens |
GSE60517
...
|
MA0112.3
|
ESR1 |
LTED (breast cancer) |
none |
Permissive
Robust
|
Homo sapiens |
GSE60517
...
|
MA0112.3
|
ESR1 |
MCF7 (Invasive ductal breast carcinoma) |
1hr with ethanol, crosslinked with 1% formaldehyde |
Permissive
Robust
|
Homo sapiens |
GSE62222
...
|
MA0112.3
|
ESR1 |
MCF7 (Invasive ductal breast carcinoma) |
1hr with 100nM E2, crosslinked with 1% formaldehyde |
Permissive
Robust
|
Homo sapiens |
GSE62222
...
|
MA0112.3
|
ESR1 |
MCF7 (Invasive ductal breast carcinoma) |
cells transfected with siNCAPG, and 1hr with 100nM E2, double crosslinked |
Permissive
Robust
|
Homo sapiens |
GSE62222
...
|
MA0112.3
|
ESR1 |
MCF7 (Invasive ductal breast carcinoma) |
cells transfected with siNCAPD3 and H2 together, and 1hr with 100nM E2, double crosslinked |
Permissive
Robust
|
Homo sapiens |
GSE62222
...
|
MA0112.3
|
ESR1 |
MCF7 (Invasive ductal breast carcinoma) |
cells transfected with siCTL, and 1hr with 100nM E2, double crosslinked |
Permissive
Robust
|
Homo sapiens |
GSE62222
...
|
MA0112.3
|
ESR1 |
MCF7 (Invasive ductal breast carcinoma) |
Vehicle |
Permissive
|
Homo sapiens |
GSE68357
...
|
MA0112.3
|
ESR1 |
MCF7 (Invasive ductal breast carcinoma) |
E2 |
Permissive
Robust
|
Homo sapiens |
GSE68357
...
|
MA0112.3
|
ESR1 |
MCF7 (Invasive ductal breast carcinoma) |
E2+PG |
Permissive
Robust
|
Homo sapiens |
GSE68357
...
|
MA0112.3
|
ESR1 |
liver |
Placebo |
Permissive
Robust
|
Mus musculus |
GSE70346
...
|
MA0112.3
|
ESR1 |
liver |
E2 |
Permissive
Robust
|
Mus musculus |
GSE70346
...
|
MA0112.3
|
ESR1 |
liver |
E2, ER KO |
Permissive
|
Mus musculus |
GSE70346
...
|
MA0112.3
|
ESR1 |
MCF7 (Invasive ductal breast carcinoma) |
sgRNA_enh588 |
Permissive
Robust
|
Homo sapiens |
GSE75779
...
|
MA0112.3
|
ESR1 |
T47D (invasive ductal carcinoma) |
sgRNA_enh588 |
Permissive
Robust
|
Homo sapiens |
GSE75779
...
|
MA0112.3
|
ESR1 |
MCF7 (Invasive ductal breast carcinoma) |
100nM E2, 120min |
Permissive
Robust
|
Homo sapiens |
GSE76893
...
|
MA0112.3
|
ESR1 |
MCF7 (Invasive ductal breast carcinoma) |
Vehicle treatment |
Permissive
Robust
|
Homo sapiens |
GSE78284
...
|
MA0112.3
|
ESR1 |
MCF7 (Invasive ductal breast carcinoma) |
E2 treatment |
Permissive
Robust
|
Homo sapiens |
GSE78284
...
|
MA0112.3
|
ESR1 |
MCF7 (Invasive ductal breast carcinoma) |
Vehicle treatment |
Permissive
Robust
|
Homo sapiens |
GSE78284
...
|
MA0112.3
|
ESR1 |
MCF7 (Invasive ductal breast carcinoma) |
E2 treatment |
Permissive
Robust
|
Homo sapiens |
GSE78284
...
|
MA0112.3
|
ESR1 |
T47D (invasive ductal carcinoma) |
Vehicle |
Permissive
|
Homo sapiens |
GSE80367
...
|
MA0112.3
|
ESR1 |
T47D (invasive ductal carcinoma) |
10 nM Estradiol |
Permissive
|
Homo sapiens |
GSE80367
...
|
MA0112.3
|
ESR1 |
T47D (invasive ductal carcinoma) |
10 nM R5020 |
Permissive
|
Homo sapiens |
GSE80367
...
|
MA0112.3
|
ESR1 |
T47D (invasive ductal carcinoma) |
10nM Estradiol + 10 nM R5020 |
Permissive
Robust
|
Homo sapiens |
GSE80367
...
|
MA0112.3
|
ESR1 |
T47D (invasive ductal carcinoma) |
Vehicle |
Permissive
|
Homo sapiens |
GSE80367
...
|
MA0112.3
|
ESR1 |
T47D (invasive ductal carcinoma) |
10 nM Estradiol |
Permissive
Robust
|
Homo sapiens |
GSE80367
...
|
MA0112.3
|
ESR1 |
T47D (invasive ductal carcinoma) |
10 nM R5020 |
Permissive
|
Homo sapiens |
GSE80367
...
|
MA0112.3
|
ESR1 |
T47D (invasive ductal carcinoma) |
10nM Estradiol + 10 nM R5020 |
Permissive
|
Homo sapiens |
GSE80367
...
|
MA0112.3
|
ESR1 |
MCF7 (Invasive ductal breast carcinoma) |
DMSO |
Permissive
Robust
|
Homo sapiens |
GSE80728
...
|
MA0112.3
|
ESR1 |
MCF7 (Invasive ductal breast carcinoma) |
E2 |
Permissive
Robust
|
Homo sapiens |
GSE80728
...
|
MA0112.3
|
ESR1 |
MCF7 (Invasive ductal breast carcinoma) |
DMSO |
Permissive
Robust
|
Homo sapiens |
GSE80728
...
|
MA0112.3
|
ESR1 |
MCF7 (Invasive ductal breast carcinoma) |
E2 |
Permissive
Robust
|
Homo sapiens |
GSE80728
...
|
MA0112.3
|
ESR1 |
endometrioid adenocarcinoma |
tumor A |
Permissive
Robust
|
Homo sapiens |
GSE81213
...
|
MA0112.3
|
ESR1 |
endometrioid adenocarcinoma |
tumor C |
Permissive
Robust
|
Homo sapiens |
GSE81213
...
|
MA0112.3
|
ESR1 |
endometrioid adenocarcinoma |
tumor D |
Permissive
|
Homo sapiens |
GSE81213
...
|
MA0112.3
|
ESR1 |
endometrioid adenocarcinoma |
tumor E |
Permissive
Robust
|
Homo sapiens |
GSE81213
...
|
MA0112.3
|
ESR1 |
endometrioid adenocarcinoma |
tumor B |
Permissive
Robust
|
Homo sapiens |
GSE81213
...
|
MA0112.3
|
ESR1 |
uterus |
IGF1 |
Permissive
Robust
|
Mus musculus |
GSE100023
...
|
MA0112.3
|
ESR1 |
uterus |
ICI 182,780 |
Permissive
Robust
|
Mus musculus |
GSE100023
...
|
MA0112.3
|
ESR1 |
U2OS (osteosarcoma) |
E2 |
Permissive
Robust
|
Homo sapiens |
GSE26110
...
|
MA0112.3
|
ESR1 |
MCF7 (Invasive ductal breast carcinoma) |
IKK7 |
Permissive
|
Homo sapiens |
GSE67295
...
|
MA0112.3
|
ESR1 |
MCF7 (Invasive ductal breast carcinoma) |
IL1b+IKK7 |
Permissive
|
Homo sapiens |
GSE67295
...
|
MA0112.3
|
ESR1 |
MCF7 (Invasive ductal breast carcinoma) |
E2+ICI |
Permissive
Robust
|
Homo sapiens |
GSE67295
...
|
MA0112.3
|
ESR1 |
MCF7 (Invasive ductal breast carcinoma) |
IL1b+ICI |
Permissive
Robust
|
Homo sapiens |
GSE67295
...
|
MA0112.3
|
ESR1 |
MCF7 (Invasive ductal breast carcinoma) |
E2 for 45m |
Permissive
Robust
|
Homo sapiens |
GSE67295
...
|
MA0112.3
|
ESR1 |
MCF7 (Invasive ductal breast carcinoma) |
IL1b for 45m |
Permissive
Robust
|
Homo sapiens |
GSE67295
...
|
MA0112.3
|
ESR1 |
MCF7 (Invasive ductal breast carcinoma) |
TNFa for 45m |
Permissive
Robust
|
Homo sapiens |
GSE67295
...
|
MA0112.3
|
ESR1 |
MCF7 (Invasive ductal breast carcinoma) |
ICI |
Permissive
Robust
|
Homo sapiens |
GSE81510
...
|
MA0112.3
|
ESR1 |
MCF7 (Invasive ductal breast carcinoma) |
E2 |
Permissive
Robust
|
Homo sapiens |
GSE81510
...
|
MA0112.3
|
ESR1 |
MCF7 (Invasive ductal breast carcinoma) |
E2, DEX |
Permissive
Robust
|
Homo sapiens |
GSE81510
...
|
MA0112.3
|
ESR1 |
T47D (invasive ductal carcinoma) |
DMSO |
Permissive
Robust
|
Homo sapiens |
GSE84593
...
|
MA0112.3
|
ESR1 |
T47D (invasive ductal carcinoma) |
BYL719 |
Permissive
Robust
|
Homo sapiens |
GSE84593
...
|
MA0112.3
|
ESR1 |
MCF7 (Invasive ductal breast carcinoma) |
control; 100 nM 17-beta-estradiol for 0h |
Permissive
|
Homo sapiens |
GSE85106
...
|
MA0112.3
|
ESR1 |
MCF7 (Invasive ductal breast carcinoma) |
100 nM 17-beta-estradiol for 45 min |
Permissive
|
Homo sapiens |
GSE85106
...
|
MA0112.3
|
ESR1 |
MCF7 (Invasive ductal breast carcinoma) |
100 nM 17-beta-estradiol for 3h |
Permissive
|
Homo sapiens |
GSE85106
...
|
MA0112.3
|
ESR1 |
MCF7 (Invasive ductal breast carcinoma) |
siCTCF |
Permissive
Robust
|
Homo sapiens |
GSE85106
...
|
MA0112.3
|
ESR1 |
MCF7 (Invasive ductal breast carcinoma) |
siNT |
Permissive
Robust
|
Homo sapiens |
GSE85106
...
|
MA0112.3
|
ESR1 |
MCF7 (Invasive ductal breast carcinoma) |
White Medium + E2 |
Permissive
Robust
|
Homo sapiens |
GSE86538
...
|
MA0112.3
|
ESR1 |
MCF7 TamR (invasive ductal breast carcinoma Tamoxifen resistant) |
White Medium |
Permissive
Robust
|
Homo sapiens |
GSE86538
...
|
MA0112.3
|
ESR1 |
MCF7 (Invasive ductal breast carcinoma) |
White Medium |
Permissive
Robust
|
Homo sapiens |
GSE86538
...
|
MA0112.3
|
ESR1 |
MCF7 (Invasive ductal breast carcinoma) |
White Medium + E2 |
Permissive
Robust
|
Homo sapiens |
GSE86538
...
|
MA0112.3
|
ESR1 |
breast tumor xenograft |
estrogen |
Permissive
Robust
|
Homo sapiens |
GSE93108
...
|
MA0112.3
|
ESR1 |
breast tumor xenograft |
estrogen plus progesterone |
Permissive
Robust
|
Homo sapiens |
GSE93108
...
|
MA0112.3
|
ESR1 |
MCF7 (Invasive ductal breast carcinoma) |
NoTreat |
Permissive
Robust
|
Homo sapiens |
GSE94023
...
|
MA0112.3
|
ESR1 |
MCF7 (Invasive ductal breast carcinoma) |
5min E2 |
Permissive
Robust
|
Homo sapiens |
GSE94023
...
|
MA0112.3
|
ESR1 |
MCF7 (Invasive ductal breast carcinoma) |
10min E2 |
Permissive
Robust
|
Homo sapiens |
GSE94023
...
|
MA0112.3
|
ESR1 |
MCF7 (Invasive ductal breast carcinoma) |
20min E2 |
Permissive
Robust
|
Homo sapiens |
GSE94023
...
|
MA0112.3
|
ESR1 |
MCF7 (Invasive ductal breast carcinoma) |
40min E2 |
Permissive
Robust
|
Homo sapiens |
GSE94023
...
|
MA0112.3
|
ESR1 |
MCF7 (Invasive ductal breast carcinoma) |
80min E2 |
Permissive
Robust
|
Homo sapiens |
GSE94023
...
|
MA0112.3
|
ESR1 |
MCF7 (Invasive ductal breast carcinoma) |
160min E2 |
Permissive
Robust
|
Homo sapiens |
GSE94023
...
|
MA0112.3
|
ESR1 |
MCF7 (Invasive ductal breast carcinoma) |
320min E2 |
Permissive
Robust
|
Homo sapiens |
GSE94023
...
|
MA0112.3
|
ESR1 |
MCF7 (Invasive ductal breast carcinoma) |
640min E2 |
Permissive
Robust
|
Homo sapiens |
GSE94023
...
|
MA0112.3
|
ESR1 |
MCF7 (Invasive ductal breast carcinoma) |
1280min E2 |
Permissive
Robust
|
Homo sapiens |
GSE94023
...
|
MA0112.3
|
ESR1 |
endometrioid adenocarcinoma |
Tamoxifen-associated |
Permissive
Robust
|
Homo sapiens |
GSE94031
...
|
MA0112.3
|
ESR1 |
endometrioid adenocarcinoma |
Tamoxifen-associated |
Permissive
|
Homo sapiens |
GSE94031
...
|
MA0112.3
|
ESR1 |
endometrioid adenocarcinoma |
Tamoxifen-associated |
Permissive
|
Homo sapiens |
GSE94031
...
|
MA0112.3
|
ESR1 |
endometrioid adenocarcinoma |
Tamoxifen-associated |
Permissive
|
Homo sapiens |
GSE94031
...
|
MA0112.3
|
ESR1 |
endometrioid adenocarcinoma |
Tamoxifen-associated |
Permissive
Robust
|
Homo sapiens |
GSE94031
...
|
MA0112.3
|
ESR1 |
endometrioid adenocarcinoma |
Tamoxifen-associated |
Permissive
|
Homo sapiens |
GSE94031
...
|
MA0112.3
|
ESR1 |
MCF7 (Invasive ductal breast carcinoma) |
Doxycycline |
Permissive
Robust
|
Homo sapiens |
GSE94493
...
|
MA0112.3
|
ESR1 |
MCF7 (Invasive ductal breast carcinoma) |
Doxycycline + E2 |
Permissive
Robust
|
Homo sapiens |
GSE94493
...
|
MA0112.3
|
ESR1 |
MCF7 (Invasive ductal breast carcinoma) |
E2 |
Permissive
Robust
|
Homo sapiens |
GSE94493
...
|
MA0112.3
|
ESR1 |
MCF7 (Invasive ductal breast carcinoma) |
Doxycycline |
Permissive
Robust
|
Homo sapiens |
GSE94493
...
|
MA0112.3
|
ESR1 |
MCF7 (Invasive ductal breast carcinoma) |
Doxycycline |
Permissive
Robust
|
Homo sapiens |
GSE94493
...
|
MA0112.3
|
ESR1 |
MCF7 (Invasive ductal breast carcinoma) |
Doxycycline + E2 |
Permissive
Robust
|
Homo sapiens |
GSE94493
...
|
MA0112.3
|
ESR1 |
MCF7 (Invasive ductal breast carcinoma) |
Doxycycline + E2 |
Permissive
Robust
|
Homo sapiens |
GSE94493
...
|
MA0112.3
|
ESR1 |
MCF7 (Invasive ductal breast carcinoma) |
E2 |
Permissive
Robust
|
Homo sapiens |
GSE94493
...
|
MA0112.3
|
ESR1 |
MCF7 (Invasive ductal breast carcinoma) |
Doxycycline |
Permissive
Robust
|
Homo sapiens |
GSE94493
...
|
MA0112.3
|
ESR1 |
MCF7 (Invasive ductal breast carcinoma) |
Doxycycline + E2 |
Permissive
Robust
|
Homo sapiens |
GSE94493
...
|
MA0112.3
|
ESR1 |
T47D (invasive ductal carcinoma) |
E2 |
Permissive
Robust
|
Homo sapiens |
GSE94493
...
|
MA0112.3
|
ESR1 |
T47D (invasive ductal carcinoma) |
Doxycycline |
Permissive
Robust
|
Homo sapiens |
GSE94493
...
|
MA0112.3
|
ESR1 |
T47D (invasive ductal carcinoma) |
Doxycycline + E2 |
Permissive
Robust
|
Homo sapiens |
GSE94493
...
|
MA0112.3
|
ESR1 |
MCF7 (Invasive ductal breast carcinoma) |
none |
Permissive
Robust
|
Homo sapiens |
GSE94493
...
|
MA0112.3
|
ESR1 |
MCF7 (Invasive ductal breast carcinoma) |
E2 |
Permissive
Robust
|
Homo sapiens |
GSE94493
...
|
MA0112.3
|
ESR1 |
MCF7 (Invasive ductal breast carcinoma) |
none |
Permissive
Robust
|
Homo sapiens |
GSE94493
...
|
MA0112.3
|
ESR1 |
MCF7 (Invasive ductal breast carcinoma) |
E2 |
Permissive
Robust
|
Homo sapiens |
GSE94493
...
|
MA0112.3
|
ESR1 |
MCF7 (Invasive ductal breast carcinoma) |
E2 |
Permissive
Robust
|
Homo sapiens |
GSE94493
...
|
MA0112.3
|
ESR1 |
MCF7 (Invasive ductal breast carcinoma) |
Doxycycline |
Permissive
Robust
|
Homo sapiens |
GSE94493
...
|
MA0112.3
|
ESR1 |
MCF7 (Invasive ductal breast carcinoma) |
Doxycycline + E2 |
Permissive
Robust
|
Homo sapiens |
GSE94493
...
|
MA0112.3
|
ESR1 |
uterus |
250 ng of estradiol (E2); mutant ERa |
Permissive
|
Mus musculus |
GSE94737
...
|
MA0112.3
|
ESR1 |
MCF7 TamR (invasive ductal breast carcinoma Tamoxifen resistant) |
vehicle |
Permissive
Robust
|
Homo sapiens |
GSE25710
...
|
MA0112.3
|
ESR1 |
MCF7 (Invasive ductal breast carcinoma) |
E2 |
Permissive
Robust
|
Homo sapiens |
GSE25710
...
|
MA0112.3
|
ESR1 |
MCF7 (Invasive ductal breast carcinoma) |
siNT |
Permissive
Robust
|
Homo sapiens |
GSE25710
...
|
MA0112.3
|
ESR1 |
MCF7 (Invasive ductal breast carcinoma) |
siFOXA1 |
Permissive
Robust
|
Homo sapiens |
GSE25710
...
|
MA0112.3
|
ESR1 |
MCF7 (Invasive ductal breast carcinoma) |
Cocktail_90 |
Permissive
Robust
|
Homo sapiens |
GSE32222
...
|
MA0112.3
|
ESR1 |
MCF7 TamR (invasive ductal breast carcinoma Tamoxifen resistant) |
Tam-Resist |
Permissive
Robust
|
Homo sapiens |
GSE32222
...
|
MA0112.3
|
ESR1 |
BT-474 (breast invasive ductal carcinoma) |
Tam-Resist |
Permissive
Robust
|
Homo sapiens |
GSE32222
...
|
MA0112.3
|
ESR1 |
ZR-75-1 (invasive ductal carcinoma) |
Tam-Responsive |
Permissive
Robust
|
Homo sapiens |
GSE32222
...
|
MA0112.3
|
ESR1 |
MCF7 (Invasive ductal breast carcinoma) |
Tam-Responsive |
Permissive
Robust
|
Homo sapiens |
GSE32222
...
|
MA0112.3
|
ESR1 |
breast tumor |
ER- |
Permissive
|
Homo sapiens |
GSE32222
...
|
MA0112.3
|
ESR1 |
breast tumour metastasis |
Metastasis |
Permissive
Robust
|
Homo sapiens |
GSE32222
...
|
MA0112.3
|
ESR1 |
breast tumor |
Non-responder |
Permissive
|
Homo sapiens |
GSE32222
...
|
MA0112.3
|
ESR1 |
breast tumor |
Responder |
Permissive
Robust
|
Homo sapiens |
GSE32222
...
|
MA0112.3
|
ESR1 |
MCF10A (breast epithelial cells) |
Cells were lentivirally transduced with MYC-ERVD and stable pools were treated with 100nM 4-OHT for 24h. |
Permissive
Robust
|
Homo sapiens |
GSE59146
...
|
MA0112.3
|
ESR1 |
MCF10A (breast epithelial cells) |
Cells were lentivirally transduced with MYC-ERVD and stable pools were treated with solvent control for 24h. |
Permissive
|
Homo sapiens |
GSE59146
...
|
MA0112.3
|
ESR1 |
MCF10A (breast epithelial cells) |
Cells were lentivirally transduced with MYC-ER and stable pools were treated with solvent control for 24h. |
Permissive
|
Homo sapiens |
GSE59146
...
|
MA0112.3
|
ESR1 |
breast tumor |
Female |
Permissive
Robust
|
Homo sapiens |
GSE104399
...
|
MA0112.3
|
ESR1 |
breast tumor |
Male |
Permissive
Robust
|
Homo sapiens |
GSE104399
...
|
MA0112.3
|
ESR1 |
MCF7 (Invasive ductal breast carcinoma) |
100 nM ICI for 30 min |
Permissive
Robust
|
Homo sapiens |
GSE108883
...
|
MA0112.3
|
ESR1 |
MCF7 (Invasive ductal breast carcinoma) |
5 nM E2 for 30 min |
Permissive
Robust
|
Homo sapiens |
GSE108883
...
|
MA0112.3
|
ESR1 |
MCF7 (Invasive ductal breast carcinoma) |
vehicle for 3h |
Permissive
Robust
|
Homo sapiens |
GSE108883
...
|
MA0112.3
|
ESR1 |
MCF7 (Invasive ductal breast carcinoma) |
ICI for 3h |
Permissive
Robust
|
Homo sapiens |
GSE108883
...
|
MA0112.3
|
ESR1 |
MCF7 (Invasive ductal breast carcinoma) |
E2 for 3h |
Permissive
Robust
|
Homo sapiens |
GSE108883
...
|
MA0112.3
|
ESR1 |
MCF7 (Invasive ductal breast carcinoma) |
control |
Permissive
Robust
|
Homo sapiens |
GSE109820
...
|
MA0112.3
|
ESR1 |
MCF7 (Invasive ductal breast carcinoma) |
100nm E2 (45 min) |
Permissive
Robust
|
Homo sapiens |
GSE109820
...
|
MA0112.3
|
ESR1 |
MCF7 (Invasive ductal breast carcinoma) |
100nm E2 (90 min) |
Permissive
Robust
|
Homo sapiens |
GSE109820
...
|
MA0112.3
|
ESR1 |
MCF7 (Invasive ductal breast carcinoma) |
control |
Permissive
Robust
|
Homo sapiens |
GSE109820
...
|
MA0112.3
|
ESR1 |
MCF7 (Invasive ductal breast carcinoma) |
100nm E2 (45 min) |
Permissive
Robust
|
Homo sapiens |
GSE109820
...
|
MA0112.3
|
ESR1 |
MCF7 (Invasive ductal breast carcinoma) |
100nm E2 (90 min) |
Permissive
Robust
|
Homo sapiens |
GSE109820
...
|
MA0112.3
|
ESR1 |
MCF7 (Invasive ductal breast carcinoma) |
control |
Permissive
Robust
|
Homo sapiens |
GSE109820
...
|
MA0112.3
|
ESR1 |
MCF7 (Invasive ductal breast carcinoma) |
100nm E2 (45 min) |
Permissive
Robust
|
Homo sapiens |
GSE109820
...
|
MA0112.3
|
ESR1 |
MCF7 (Invasive ductal breast carcinoma) |
100nm E2 (90 min) |
Permissive
Robust
|
Homo sapiens |
GSE109820
...
|
MA0112.3
|
ESR1 |
MCF7 (Invasive ductal breast carcinoma) |
control |
Permissive
Robust
|
Homo sapiens |
GSE109820
...
|
MA0112.3
|
ESR1 |
MCF7 (Invasive ductal breast carcinoma) |
100nm E2 (45 min) |
Permissive
Robust
|
Homo sapiens |
GSE109820
...
|
MA0112.3
|
ESR1 |
MCF7 (Invasive ductal breast carcinoma) |
100nm E2 (90 min) |
Permissive
Robust
|
Homo sapiens |
GSE109820
...
|
MA0112.3
|
ESR1 |
MCF7 (Invasive ductal breast carcinoma) |
Source: cJun - Tet cells; CellType: ERalpha-positive breast cancer cells; Treatment: ethanol 1hr; |
Permissive
Robust
|
Homo sapiens |
GSE102410
...
|
MA0112.3
|
ESR1 |
MCF7 (Invasive ductal breast carcinoma) |
Source: cJun - Tet cells; CellType: ERalpha-positive breast cancer cells; Treatment: 17beta estradiol 10nM for 1hr; |
Permissive
Robust
|
Homo sapiens |
GSE102410
...
|
MA0112.3
|
ESR1 |
MCF7 (Invasive ductal breast carcinoma) |
Source: cJun - Tet cells; CellType: ERalpha-positive breast cancer cells; Treatment: tamoxifen 1μM for 1hr; |
Permissive
Robust
|
Homo sapiens |
GSE102410
...
|
MA0112.3
|
ESR1 |
MCF7 (Invasive ductal breast carcinoma) |
Treatment: vehicle(DMSO 2 hr); Passage: p19; |
Permissive
Robust
|
Homo sapiens |
GSE103023
...
|
MA0112.3
|
ESR1 |
MCF7 (Invasive ductal breast carcinoma) |
Treatment: 500nM RAD001 2hr; Passage: p19; |
Permissive
Robust
|
Homo sapiens |
GSE103023
...
|
MA0112.3
|
ESR1 |
MCF7 (Invasive ductal breast carcinoma) |
Treatment: 500 nM AZD201 2 hr; Passage: p19; |
Permissive
Robust
|
Homo sapiens |
GSE103023
...
|
MA0112.3
|
ESR1 |
MCF7 (Invasive ductal breast carcinoma) |
Treatment: vehicle(DMSO 2 hr); Passage: p20; |
Permissive
Robust
|
Homo sapiens |
GSE103023
...
|
MA0112.3
|
ESR1 |
MCF7 (Invasive ductal breast carcinoma) |
Treatment: 500nM RAD001 2hr; Passage: p20; |
Permissive
Robust
|
Homo sapiens |
GSE103023
...
|
MA0112.3
|
ESR1 |
MCF7 (Invasive ductal breast carcinoma) |
Treatment: 500 nM AZD201 2 hr; Passage: p20; |
Permissive
Robust
|
Homo sapiens |
GSE103023
...
|
MA0112.3
|
ESR1 |
MCF7 (Invasive ductal breast carcinoma) |
Treatment: vehicle(DMSO 2 hr); Passage: p21; |
Permissive
Robust
|
Homo sapiens |
GSE103023
...
|
MA0112.3
|
ESR1 |
MCF7 (Invasive ductal breast carcinoma) |
Treatment: 500nM RAD001 2hr; Passage: p21; |
Permissive
Robust
|
Homo sapiens |
GSE103023
...
|
MA0112.3
|
ESR1 |
MCF7 (Invasive ductal breast carcinoma) |
Treatment: 500 nM AZD201 2 hr; Passage: p21; |
Permissive
Robust
|
Homo sapiens |
GSE103023
...
|
MA0112.3
|
ESR1 |
MCF7 (Invasive ductal breast carcinoma) |
Treatment: vehicle(DMSO 2 hr); Passage: p22; |
Permissive
Robust
|
Homo sapiens |
GSE103023
...
|
MA0112.3
|
ESR1 |
MCF7 (Invasive ductal breast carcinoma) |
Treatment: 500nM RAD001 2hr; Passage: p22; |
Permissive
Robust
|
Homo sapiens |
GSE103023
...
|
MA0112.3
|
ESR1 |
MCF7 (Invasive ductal breast carcinoma) |
Treatment: 500 nM AZD201 2 hr; Passage: p22; |
Permissive
Robust
|
Homo sapiens |
GSE103023
...
|
MA0112.3
|
ESR1 |
T47D (invasive ductal carcinoma) |
CellType: Mammary gland adenocarcarcinoma epithelial ceslls derived from metastatic site Modifications: parental cells |
Permissive
|
Homo sapiens |
GSE107176
...
|
MA0112.3
|
ESR1 |
MDA-MB-134 (invasive lobular breast carcinoma) |
Treatment: DMSO Passage: between 10 and12 CellType: Epithelial ERalpha positive breast cancer cell line |
Permissive
Robust
|
Homo sapiens |
GSE109103
...
|
MA0112.3
|
ESR1 |
MDA-MB-134 (invasive lobular breast carcinoma) |
Treatment: 100 nM estradiol (E2) for 1hr Passage: between 10 and12 CellType: Epithelial ERalpha positive breast cancer cell line |
Permissive
Robust
|
Homo sapiens |
GSE109103
...
|
MA0112.3
|
ESR1 |
MDA-MB-134 (invasive lobular breast carcinoma) |
Treatment: a cocktail of 10 µM forskolin plus 100 µM 3-isobutyl-1-methylxanthine (FI) for 1hr Passage: between 10 and12 CellType: Epithelial ERalpha positive breast cancer cell line |
Permissive
Robust
|
Homo sapiens |
GSE109103
...
|
MA0112.3
|
ESR1 |
Ishikawa (endometrial adenocarcinoma) |
Treatment: 100 nM Dexamethasone and 10 nM Estradiol for 1 hour |
Permissive
Robust
|
Homo sapiens |
GSE109891
...
|
MA0112.3
|
ESR1 |
Ishikawa (endometrial adenocarcinoma) |
Treatment: 10 nM Estradiol for 1 hour |
Permissive
Robust
|
Homo sapiens |
GSE109891
...
|
MA0112.3
|
ESR1 |
Ishikawa (endometrial adenocarcinoma) |
Treatment: DMSO (vehicle) for 1 hour |
Permissive
|
Homo sapiens |
GSE109891
...
|
MA0112.3
|
ESR1 |
MCF7 (Invasive ductal breast carcinoma) |
DMSO |
Permissive
|
Homo sapiens |
GSE115607
...
|
MA0112.3
|
ESR1 |
MCF7 (Invasive ductal breast carcinoma) |
H3B-6545 |
Permissive
Robust
|
Homo sapiens |
GSE115607
...
|
MA0112.3
|
ESR1 |
MCF7 (Invasive ductal breast carcinoma) |
Saturated H3B-6545 |
Permissive
Robust
|
Homo sapiens |
GSE115607
...
|
MA0112.3
|
ESR1 |
MCF7 (Invasive ductal breast carcinoma) |
800 |
Permissive
Robust
|
Homo sapiens |
GSE115607
...
|
MA0112.3
|
ESR1 |
MCF7 (Invasive ductal breast carcinoma) |
Rad1901 |
Permissive
Robust
|
Homo sapiens |
GSE115607
...
|
MA0112.3
|
ESR1 |
MCF7 (Invasive ductal breast carcinoma) |
H3B-5942 |
Permissive
Robust
|
Homo sapiens |
GSE115607
...
|
MA0112.3
|
ESR1 |
MCF7 (Invasive ductal breast carcinoma) |
Saturated H3B-5942 |
Permissive
Robust
|
Homo sapiens |
GSE115607
...
|
MA0112.3
|
ESR1 |
MCF7 (Invasive ductal breast carcinoma) |
Tamoxifen |
Permissive
Robust
|
Homo sapiens |
GSE115607
...
|
MA0112.3
|
ESR1 |
MCF7 (Invasive ductal breast carcinoma) |
Fulvestrant |
Permissive
Robust
|
Homo sapiens |
GSE115607
...
|
MA0112.3
|
ESR1 |
MCF7 (Invasive ductal breast carcinoma) |
E2 |
Permissive
Robust
|
Homo sapiens |
GSE115607
...
|
MA0112.3
|
ESR1 |
T47D (invasive ductal carcinoma) |
Treatment: Hormone-deprived media using RPMI1640 without phenol red and 10% charcoal-stripped FBS) for 5-7 days |
Permissive
Robust
|
Homo sapiens |
GSE116170
...
|
MA0112.3
|
ESR1 |
T47D (invasive ductal carcinoma) |
CellSubtype:Stable ESR1-YAP1 fusion expressing model Treatment: Hormone-deprived media using RPMI1640 without phenol red and 10% charcoal-stripped FBS) for 5-7 days |
Permissive
|
Homo sapiens |
GSE116170
...
|
MA0112.3
|
ESR1 |
T47D (invasive ductal carcinoma) |
CellSubtype: stable ESR1-PCDH11X fusion expressing model Treatment: Hormone-deprived media using RPMI1640 without phenol red and 10% charcoal-stripped FBS) for 5-7 days |
Permissive
Robust
|
Homo sapiens |
GSE116170
...
|
MA0112.3
|
ESR1 |
T47D (invasive ductal carcinoma) |
CellSubtype: stable ESR1-NOP2 fusion expressing model Treatment: hormone-deprived media using RPMI1640 without phenol red and 10% charcoal-stripped FBS) for 5-7 days |
Permissive
|
Homo sapiens |
GSE116170
...
|
MA0112.3
|
ESR1 |
T47D (invasive ductal carcinoma) |
CellSubtype: stable YFP-HA expressing model Treatment: Hormone-deprived media using RPMI1640 without phenol red and 10% charcoal-stripped FBS) for 5-7 days |
Permissive
|
Homo sapiens |
GSE116170
...
|
MA0112.3
|
ESR1 |
MCF7 (Invasive ductal breast carcinoma) |
Treatment: DMSO for 45 min Genotype: wildtype TET2 Passage: 6-10 |
Permissive
Robust
|
Homo sapiens |
GSE120756
...
|
MA0112.3
|
ESR1 |
MCF7 (Invasive ductal breast carcinoma) |
Treatment: E2 (estrogen) for 45 min Genotype: wildtype TET2 Passage: 6-10 |
Permissive
Robust
|
Homo sapiens |
GSE120756
...
|
MA0112.3
|
ESR1 |
MCF7 (Invasive ductal breast carcinoma) |
Treatment: DMSO for 45 min Genotype: TET2 knockout Passage: 6-10 |
Permissive
Robust
|
Homo sapiens |
GSE120756
...
|
MA0112.3
|
ESR1 |
MCF7 (Invasive ductal breast carcinoma) |
Treatment: E2 (estrogen) for 45 min Genotype: TET2 knockout Passage: 6-10 |
Permissive
Robust
|
Homo sapiens |
GSE120756
...
|
MA0112.3
|
ESR1 |
MCF7 (Invasive ductal breast carcinoma) |
Treatment: DMSO for 45 min Genotype: wildtype TET2 Passage: 6-10 |
Permissive
|
Homo sapiens |
GSE120756
...
|
MA0112.3
|
ESR1 |
MCF7 (Invasive ductal breast carcinoma) |
Treatment: E2 (estrogen) for 45 min Genotype: wildtype TET2 Passage: 6-10 |
Permissive
Robust
|
Homo sapiens |
GSE120756
...
|
MA0112.3
|
ESR1 |
MDA-MB-231 (breast adenocarcinoma) |
treatment: E2, 100 nM, 0 min Genotype: ER-alfa wildtype |
Permissive
|
Homo sapiens |
GSE95121
...
|
MA0112.3
|
ESR1 |
MDA-MB-231 (breast adenocarcinoma) |
Treatment: E2, 100 nM, 45 min Genotype: ER-alfa wildtype |
Permissive
Robust
|
Homo sapiens |
GSE95121
...
|
MA0112.3
|
ESR1 |
MDA-MB-231 (breast adenocarcinoma) |
Treatment: E2, 100 nM, 0 min Genotype: ER-alfa L540Q |
Permissive
|
Homo sapiens |
GSE95121
...
|
MA0112.3
|
ESR1 |
MDA-MB-231 (breast adenocarcinoma) |
Treatment: E2, 100 nM, 0 min Genotype: ER-alfa L540Q |
Permissive
Robust
|
Homo sapiens |
GSE95121
...
|
MA0112.3
|
ESR1 |
T47D (invasive ductal carcinoma) |
Passsage: <10 |
Permissive
Robust
|
Homo sapiens |
GSE99479
...
|
MA0112.3
|
ESR1 |
T47D (invasive ductal carcinoma) |
Passsage: <10 |
Permissive
Robust
|
Homo sapiens |
GSE99479
...
|
MA0112.3
|
ESR1 |
T47D (invasive ductal carcinoma) |
Passsage: <10 Genotype: wt/R330fs mutant with CRISPR |
Permissive
Robust
|
Homo sapiens |
GSE99479
...
|
MA0112.3
|
ESR1 |
T47D (invasive ductal carcinoma) |
Passsage: <10 Genotype: wt/R330fs mutant with CRISPR |
Permissive
Robust
|
Homo sapiens |
GSE99479
...
|
MA0112.3
|
ESR1 |
MCF7 (Invasive ductal breast carcinoma) |
Treatment: 10nM Estradiol + 10 nM DHT for 45 mins Genotype: ER+/PR+ |
Permissive
|
Homo sapiens |
GSE99626
...
|
MA0112.3
|
ESR1 |
MCF7 (Invasive ductal breast carcinoma) |
Treatment: Vehicle for 60 mins Genotype: ER+/PR+ |
Permissive
Robust
|
Homo sapiens |
GSE99626
...
|
MA0112.3
|
ESR1 |
MCF7 (Invasive ductal breast carcinoma) |
Treatment: 10 nM Dexamethasone for 60 mins Genotype: ER+/PR+ |
Permissive
Robust
|
Homo sapiens |
GSE99626
...
|
MA0112.3
|
ESR1 |
MCF7 (Invasive ductal breast carcinoma) |
Treatment: 15 mins of 10nM Estradiol and then 10nM Estradiol + 10 nM Dexamethasone for 60 mins Genotype: ER+/PR+ |
Permissive
Robust
|
Homo sapiens |
GSE99626
...
|
MA0112.3
|
ESR1 |
MCF7 (Invasive ductal breast carcinoma) |
Treatment: 10 nM Aldosterone for 45 mins Genotype: ER+/PR+ |
Permissive
|
Homo sapiens |
GSE99626
...
|
MA0112.3
|
ESR1 |
MCF7 (Invasive ductal breast carcinoma) |
Treatment: 10nM Estradiol + 10 nM Aldosterone for 45 mins Genotype: ER+/PR+ |
Permissive
Robust
|
Homo sapiens |
GSE99626
...
|
MA0112.3
|
ESR1 |
MCF7 (Invasive ductal breast carcinoma) |
10nM Estradiol + 10 nM Dexamethasone |
Permissive
|
Homo sapiens |
GSE99626
...
|
MA0112.3
|
ESR1 |
MCF7 (Invasive ductal breast carcinoma) |
Treatment: Vehicle for4 hrs Genotype: ER+/PR+ |
Permissive
Robust
|
Homo sapiens |
GSE99626
...
|
MA0112.3
|
ESR1 |
MCF7 (Invasive ductal breast carcinoma) |
Treatment: 10 nM E2 for4 hrs Genotype: ER+/PR+ |
Permissive
Robust
|
Homo sapiens |
GSE99626
...
|
MA0112.3
|
ESR1 |
MCF7 (Invasive ductal breast carcinoma) |
Treatment: 10 nM R5020 for45 mins Genotype: ER+/PR+ |
Permissive
Robust
|
Homo sapiens |
GSE99626
...
|
MA0112.3
|
ESR1 |
MCF7 (Invasive ductal breast carcinoma) |
Treatment: 10 nM E2 + 10 nM R5020 for45 mins Genotype: ER+/PR+ |
Permissive
Robust
|
Homo sapiens |
GSE99626
...
|
MA0112.3
|
ESR1 |
MCF7 (Invasive ductal breast carcinoma) |
Treatmet: Vehicle, 45 min Genotype: ER+/PR+ |
Permissive
|
Homo sapiens |
GSE99626
...
|
MA0112.3
|
ESR1 |
MCF7 (Invasive ductal breast carcinoma) |
Treatment: 10 nM Estradiol for 45 mins Genotype: ER+/PR+ |
Permissive
Robust
|
Homo sapiens |
GSE99626
...
|
MA0112.3
|
ESR1 |
MCF7 (Invasive ductal breast carcinoma) |
Treatment: FA (control) |
Permissive
Robust
|
Homo sapiens |
GSE114737
...
|
MA0112.3
|
ESR1 |
MCF7 (Invasive ductal breast carcinoma) |
Treatment: 2 mM DSG for 25 mins |
Permissive
Robust
|
Homo sapiens |
GSE114737
...
|
MA0112.3
|
ESR1 |
primary breast cancer |
Treatment: 2 mM DSG for 25 mins |
Permissive
Robust
|
Homo sapiens |
GSE114737
...
|
MA0112.3
|
ESR1 |
primary endometrium cancer |
Treatment: FA (control) |
Permissive
Robust
|
Homo sapiens |
GSE114737
...
|
MA0112.3
|
ESR1 |
primary endometrium cancer |
Treatment: 2 mM DSG for 25 mins |
Permissive
Robust
|
Homo sapiens |
GSE114737
...
|
MA0112.3
|
ESR1 |
MCF7 (Invasive ductal breast carcinoma) |
Treatment: 10 nM 17-beta-estradiol for 30 mins Genotype: pS118-ER |
Permissive
|
Homo sapiens |
GSE117569
...
|
MA0112.3
|
ESR1 |
MCF7 (Invasive ductal breast carcinoma) |
Treatment: vehicle (0.01% EtOH) for 30 mins Genotype: pS118-ER |
Permissive
|
Homo sapiens |
GSE117569
...
|
MA0112.3
|
ESR1 |
MCF7 (Invasive ductal breast carcinoma) |
Treatment: 10 nM 17-beta-estradiol for 30 mins Genotype: pS118-ER |
Permissive
Robust
|
Homo sapiens |
GSE117569
...
|
MA0112.3
|
ESR1 |
MCF7 (Invasive ductal breast carcinoma) |
Treatment: vehicle (0.01% EtOH) for 30 mins Genotype: pS118-ER |
Permissive
Robust
|
Homo sapiens |
GSE117569
...
|
MA0112.3
|
ESR1 |
MCF7 (Invasive ductal breast carcinoma) |
Treatment: 10 nM 17-beta-estradiol for 30 mins Genotype: pS118-ER |
Permissive
Robust
|
Homo sapiens |
GSE117569
...
|
MA0112.3
|
ESR1 |
MCF7 (Invasive ductal breast carcinoma) |
Treatment: vehicle (0.01% EtOH) for 30 mins Genotype: pS118-ER |
Permissive
|
Homo sapiens |
GSE117569
...
|
MA0112.3
|
ESR1 |
MCF7 (Invasive ductal breast carcinoma) |
Treatment: 10 nM 17-beta-estradiol for 30 mins Genotype: wildtype ER |
Permissive
Robust
|
Homo sapiens |
GSE117569
...
|
MA0112.3
|
ESR1 |
MCF7 (Invasive ductal breast carcinoma) |
Treatment: vehicle (0.01% EtOH) for 30 mins Genotype: wildtype-ER |
Permissive
Robust
|
Homo sapiens |
GSE117569
...
|
MA0112.3
|
ESR1 |
B-cells |
Genotype: wildtype; Strain: C57BL/6; Tissue: spleen; |
Permissive
|
Mus musculus |
GSE66424
...
|
MA0112.3
|
ESR1 |
MCF7L-P(immortalized breast epithelial cell line) |
Treatment: untreated; |
Permissive
Robust
|
Homo sapiens |
GSE108787
...
|
MA0112.3
|
ESR1 |
MCF7L-P(immortalized breast epithelial cell line) |
Treatment: treated with E2 for 1 hr; |
Permissive
Robust
|
Homo sapiens |
GSE108787
...
|
MA0112.3
|
ESR1 |
MCF7L-P(immortalized breast epithelial cell line) |
Treatment: treated with E2 for 4 hrs; |
Permissive
Robust
|
Homo sapiens |
GSE108787
...
|
MA0112.3
|
ESR1 |
MCF7L-P(immortalized breast epithelial cell line) |
Treatment: treated with E2 for 16 hrs; |
Permissive
Robust
|
Homo sapiens |
GSE108787
...
|
MA0112.3
|
ESR1 |
MCF7L-P(immortalized breast epithelial cell line) |
Treatment: treated with E2 for 24 hrs; |
Permissive
Robust
|
Homo sapiens |
GSE108787
...
|
MA0112.3
|
ESR1 |
MCF7 (Invasive ductal breast carcinoma) |
Treatment: with Estrogen; |
Permissive
Robust
|
Homo sapiens |
GSE117492
...
|
MA0112.3
|
ESR1 |
MCF7 (Invasive ductal breast carcinoma) |
Treatment: with Estrogen +1,6-Hexanediol; |
Permissive
Robust
|
Homo sapiens |
GSE117492
...
|
MA0112.3
|
ESR1 |
sperm |
Strain: CD1; |
Permissive
|
Mus musculus |
GSE116855
...
|
MA0112.3
|
ESR1 |
uterus |
Age: adult; Treatment: 250 ng E2 dissolved in 0.1 ml of normal saline for 6 hrs; Strain: C57BL/6J; |
Permissive
Robust
|
Mus musculus |
GSE125972
...
|
MA0112.3
|
ESR1 |
uterus |
Age: adult; Treatment: 250 ng E2 dissolved in 0.1 ml of normal saline for 8 hrs; Strain: C57BL/6J; |
Permissive
Robust
|
Mus musculus |
GSE125972
...
|
MA0112.3
|
ESR1 |
uterus |
Age: adult; Treatment: 250 ng E2 dissolved in 0.1 ml of normal saline for 12 hrs; Strain: C57BL/6J; |
Permissive
Robust
|
Mus musculus |
GSE125972
...
|
MA0112.3
|
ESR1 |
uterus |
Age: 21 day; Treatment: 250 ng E2 dissolved in 0.1 ml of normal saline; Strain: C57BL/6J; |
Permissive
|
Mus musculus |
GSE125972
...
|
MA0112.3
|
ESR1 |
T47D (invasive ductal carcinoma) |
E2_TAM |
Permissive
Robust
|
Homo sapiens |
ERP000380
|
MA0112.3
|
ESR1 |
ZR-75-1 (invasive ductal carcinoma) |
E2_TAM |
Permissive
Robust
|
Homo sapiens |
ERP000380
|
MA0112.3
|
ESR1 |
MCF7 (Invasive ductal breast carcinoma) |
E2 |
Permissive
Robust
|
Homo sapiens |
ERP000901
|
MA0112.3
|
ESR1 |
MCF7 (Invasive ductal breast carcinoma) |
LY2 |
Permissive
Robust
|
Homo sapiens |
ERP003844
|
MA0112.3
|
ESR1 |
MCF7 (Invasive ductal breast carcinoma) |
E2 |
Permissive
Robust
|
Homo sapiens |
GSE14664
|
MA0112.3
|
ESR1 |
HCC-1428 (breast adenocarcinoma) |
TLED |
Permissive
|
Homo sapiens |
GSE27300
|
MA0112.3
|
ESR1 |
MCF7 (Invasive ductal breast carcinoma) |
TLED |
Permissive
Robust
|
Homo sapiens |
GSE27300
|
MA0112.3
|
ESR1 |
MCF7 (Invasive ductal breast carcinoma) |
SHESR1 |
Permissive
Robust
|
Homo sapiens |
GSE53531
|
MA0112.3
|
ESR1 |
MCF7 (Invasive ductal breast carcinoma) |
E2_JQ1 |
Permissive
Robust
|
Homo sapiens |
GSE55921
|
MA0112.3
|
ESR1 |
T47D (invasive ductal carcinoma) |
E2 |
Permissive
Robust
|
Homo sapiens |
GSE68356
|
MA0112.3
|
ESR1 |
MCF7 (Invasive ductal breast carcinoma) |
|
Permissive
|
Homo sapiens |
GSE26083
...
|
MA0112.3
|
ESR1 |
MCF7 (Invasive ductal breast carcinoma) |
|
Permissive
|
Homo sapiens |
GSE33804
...
|
MA0112.3
|
ESR1 |
MCF7 (Invasive ductal breast carcinoma) |
|
Permissive
|
Homo sapiens |
GSE24166
...
|
MA0112.3
|
ESR1 |
liver |
|
Permissive
Robust
|
Mus musculus |
GSE49993
...
|
MA0112.3
|
ESR1 |
uterus |
|
Permissive
Robust
|
Mus musculus |
GSE49993
...
|
MA0112.3
|
ESR1 |
mammary gland |
|
Permissive
Robust
|
Mus musculus |
GSE43415
...
|
MA0112.3
|
ESR1 |
MCF7 (Invasive ductal breast carcinoma) |
|
Permissive
Robust
|
Homo sapiens |
GSE49390
...
|
MA0112.3
|
ESR1 |
MCF7 (Invasive ductal breast carcinoma) |
|
Permissive
Robust
|
Homo sapiens |
GSE49390
...
|
MA0112.3
|
ESR1 |
MCF10A (breast epithelial cells) |
|
Permissive
Robust
|
Homo sapiens |
GSE59001
...
|
MA0112.3
|
ESR1 |
preantral follicles |
|
Permissive
Robust
|
Mus musculus |
GSE62545
...
|
MA0112.3
|
ESR1 |
MCF7 (Invasive ductal breast carcinoma) |
|
Permissive
|
Homo sapiens |
GSE73320
...
|
MA0112.3
|
ESR1 |
T47D (invasive ductal carcinoma) |
|
Permissive
Robust
|
Homo sapiens |
GSE74033
...
|
MA0112.3
|
ESR1 |
MCF7 (Invasive ductal breast carcinoma) |
|
Permissive
Robust
|
Homo sapiens |
GSE75779
...
|
MA0112.3
|
ESR1 |
T47D (invasive ductal carcinoma) |
|
Permissive
Robust
|
Homo sapiens |
GSE75779
...
|
MA0112.3
|
ESR1 |
mammary gland |
|
Permissive
|
Mus musculus |
GSE77586
...
|
MA0112.3
|
ESR1 |
MCF7 (Invasive ductal breast carcinoma) |
|
Permissive
|
Homo sapiens |
GSE67295
...
|
MA0112.3
|
ESR1 |
patient-derived pleaural effusion |
N/A |
Permissive
Robust
|
Homo sapiens |
GSE86538
...
|
MA0112.3
|
ESR1 |
endometrioid adenocarcinoma |
|
Permissive
|
Homo sapiens |
GSE94031
...
|
MA0112.3
|
ESR1 |
endometrioid adenocarcinoma |
|
Permissive
Robust
|
Homo sapiens |
GSE94031
...
|
MA0112.3
|
ESR1 |
endometrioid adenocarcinoma |
|
Permissive
|
Homo sapiens |
GSE94031
...
|
MA0112.3
|
ESR1 |
endometrioid adenocarcinoma |
|
Permissive
|
Homo sapiens |
GSE94031
...
|
MA0112.3
|
ESR1 |
endometrioid adenocarcinoma |
|
Permissive
|
Homo sapiens |
GSE94031
...
|
MA0112.3
|
ESR1 |
endometrioid adenocarcinoma |
|
Permissive
|
Homo sapiens |
GSE94031
...
|
MA0112.3
|
ESR1 |
MCF7 (Invasive ductal breast carcinoma) |
|
Permissive
Robust
|
Homo sapiens |
GSE25710
...
|
MA0112.3
|
ESR1 |
MCF7 (Invasive ductal breast carcinoma) |
|
Permissive
Robust
|
Homo sapiens |
GSE25710
...
|
MA0112.3
|
ESR1 |
MCF7 (Invasive ductal breast carcinoma) |
|
Permissive
Robust
|
Homo sapiens |
GSE25710
...
|
MA0112.3
|
ESR1 |
T47D (invasive ductal carcinoma) |
|
Permissive
Robust
|
Homo sapiens |
GSE25710
...
|
MA0112.3
|
ESR1 |
MCF7 (Invasive ductal breast carcinoma) |
|
Permissive
Robust
|
Homo sapiens |
GSE116768
...
|
MA0112.3
|
ESR1 |
MCF7L-TamR(immortalized breast epithelial, tamoxifen resistant cell line) |
|
Permissive
Robust
|
Homo sapiens |
GSE108787
...
|
MA0112.3
|
ESR1 |
MCF7 (Invasive ductal breast carcinoma) |
|
Permissive
Robust
|
Homo sapiens |
ERP000783
|
MA0112.3
|
ESR1 |
ZR-75-1 (invasive ductal carcinoma) |
|
Permissive
Robust
|
Homo sapiens |
ERP000783
|
MA0112.3
|
ESR1 |
|
|
Permissive
Robust
|
Homo sapiens |
ERP003828
|
MA0112.3
|
ESR1 |
MCF7 (Invasive ductal breast carcinoma) |
|
Permissive
|
Homo sapiens |
GSE35109
|
MA0112.3
|
ESR1 |
MCF7 (Invasive ductal breast carcinoma) |
|
Permissive
Robust
|
Homo sapiens |
GSE41561
|
MA0112.3
|
ESR1 |
MCF7 (Invasive ductal breast carcinoma) |
|
Permissive
Robust
|
Homo sapiens |
GSE45822
|
MA0112.3
|
ESR1 |
MCF7 (Invasive ductal breast carcinoma) |
|
Permissive
Robust
|
Homo sapiens |
GSE48930
|
MA0112.3
|
ESR1 |
|
|
Permissive
Robust
|
Homo sapiens |
GSE68356
|
MA0112.3
|
ESR1 |
|
|
Permissive
|
Homo sapiens |
GSE68356
|
MA0112.3
|
ESR1 |
|
|
Permissive
Robust
|
Homo sapiens |
GSE68356
|
MA0112.3
|
ESR1 |
|
|
Permissive
|
Homo sapiens |
GSE68356
|
MA0112.3
|
ESR1 |
MCF7 (Invasive ductal breast carcinoma) |
E2 |
Permissive
Robust
|
Homo sapiens |
ERP000209
|
MA0112.3
|
ESR1 |
MCF7 (Invasive ductal breast carcinoma) |
E2 |
Permissive
Robust
|
Homo sapiens |
ERP000380
|
MA0112.3
|
ESR1 |
MCF7 (Invasive ductal breast carcinoma) |
E2_TAM |
Permissive
Robust
|
Homo sapiens |
ERP000380
|
MA0112.3
|
ESR1 |
MCF7 (Invasive ductal breast carcinoma) |
SHCRT_E2 |
Permissive
Robust
|
Homo sapiens |
ERP000380
|
MA0112.3
|
ESR1 |
MCF7 (Invasive ductal breast carcinoma) |
SHFOXA1_E2 |
Permissive
Robust
|
Homo sapiens |
ERP000380
|
MA0112.3
|
ESR1 |
MCF7 (Invasive ductal breast carcinoma) |
TAM |
Permissive
Robust
|
Homo sapiens |
ERP000380
|
MA0112.3
|
ESR1 |
MCF7 (Invasive ductal breast carcinoma) |
TAMR |
Permissive
Robust
|
Homo sapiens |
ERP000380
|
MA0112.3
|
ESR1 |
MCF7 (Invasive ductal breast carcinoma) |
TAMR_TAM |
Permissive
Robust
|
Homo sapiens |
ERP000380
|
MA0112.3
|
ESR1 |
|
glyc |
Permissive
Robust
|
Homo sapiens |
ERP002305
|
MA0112.3
|
ESR1 |
|
mrnahist |
Permissive
|
Homo sapiens |
ERP002305
|
MA0112.3
|
ESR1 |
MCF7 (Invasive ductal breast carcinoma) |
GLYC |
Permissive
Robust
|
Homo sapiens |
ERP002305
|
MA0112.3
|
ESR1 |
MCF7 (Invasive ductal breast carcinoma) |
MRNAHIST |
Permissive
Robust
|
Homo sapiens |
ERP002305
|
MA0112.3
|
ESR1 |
H3396 (breast carcinoma) |
E2 |
Permissive
Robust
|
Homo sapiens |
GSE32349
|
MA0112.3
|
ESR1 |
H3396 (breast carcinoma) |
ETOH |
Permissive
Robust
|
Homo sapiens |
GSE32349
|
MA0112.3
|
ESR1 |
MCF7 (Invasive ductal breast carcinoma) |
SICTR_E2 |
Permissive
Robust
|
Homo sapiens |
GSE40129
|
MA0112.3
|
ESR1 |
MCF7 (Invasive ductal breast carcinoma) |
SIGATA_E2 |
Permissive
Robust
|
Homo sapiens |
GSE40129
|
MA0112.3
|
ESR1 |
ZR-75-1 (invasive ductal carcinoma) |
SICTR_E2 |
Permissive
Robust
|
Homo sapiens |
GSE40129
|
MA0112.3
|
ESR1 |
ZR-75-1 (invasive ductal carcinoma) |
SIGATA_E2 |
Permissive
Robust
|
Homo sapiens |
GSE40129
|
MA0112.3
|
ESR1 |
|
tumor_BADOUTCOME |
Permissive
|
Homo sapiens |
GSE40867
|
MA0112.3
|
ESR1 |
|
tumor_GOODOUTCOME |
Permissive
Robust
|
Homo sapiens |
GSE40867
|
MA0112.3
|
ESR1 |
VCaP (prostate carcinoma) |
E2 |
Permissive
|
Homo sapiens |
GSE43985
|
MA0112.3
|
ESR1 |
VCaP (prostate carcinoma) |
E2_ERA |
Permissive
Robust
|
Homo sapiens |
GSE43985
|
MA0112.3
|
ESR1 |
MDA-MB-134 (invasive lobular breast carcinoma) |
ESTROGEN |
Permissive
|
Homo sapiens |
GSE51022
|
MA0112.3
|
ESR1 |
MDA-MB-134 (invasive lobular breast carcinoma) |
ETOH |
Permissive
Robust
|
Homo sapiens |
GSE51022
|
MA0112.3
|
ESR1 |
MCF7 (Invasive ductal breast carcinoma) |
LETR |
Permissive
Robust
|
Homo sapiens |
GSE54592
|
MA0112.3
|
ESR1 |
MCF7 (Invasive ductal breast carcinoma) |
LETR_ANDRO |
Permissive
Robust
|
Homo sapiens |
GSE54592
|
MA0112.3
|
ESR1 |
MCF7 (Invasive ductal breast carcinoma) |
LY2_ETOH |
Permissive
Robust
|
Homo sapiens |
GSE54592
|
MA0112.3
|
ESR1 |
MCF7 (Invasive ductal breast carcinoma) |
E2_10M |
Permissive
Robust
|
Homo sapiens |
GSE54855
|
MA0112.3
|
ESR1 |
MCF7 (Invasive ductal breast carcinoma) |
E2_120M |
Permissive
Robust
|
Homo sapiens |
GSE54855
|
MA0112.3
|
ESR1 |
MCF7 (Invasive ductal breast carcinoma) |
E2_2M |
Permissive
Robust
|
Homo sapiens |
GSE54855
|
MA0112.3
|
ESR1 |
MCF7 (Invasive ductal breast carcinoma) |
E2_40M |
Permissive
Robust
|
Homo sapiens |
GSE54855
|
MA0112.3
|
ESR1 |
MCF7 (Invasive ductal breast carcinoma) |
E2_5M |
Permissive
Robust
|
Homo sapiens |
GSE54855
|
MA0112.3
|
ESR1 |
MCF7 (Invasive ductal breast carcinoma) |
E2 |
Permissive
Robust
|
Homo sapiens |
GSE59530
|
MA0112.3
|
ESR1 |
MCF7 (Invasive ductal breast carcinoma) |
E2_TNF |
Permissive
Robust
|
Homo sapiens |
GSE59530
|
MA0112.3
|
ESR1 |
MCF7 (Invasive ductal breast carcinoma) |
SHCTR_E2_TNF |
Permissive
Robust
|
Homo sapiens |
GSE59530
|
MA0112.3
|
ESR1 |
MCF7 (Invasive ductal breast carcinoma) |
SHFOXA1_E2_TNF |
Permissive
Robust
|
Homo sapiens |
GSE59530
|
MA0112.3
|
ESR1 |
MCF7 (Invasive ductal breast carcinoma) |
TNF |
Permissive
Robust
|
Homo sapiens |
GSE59530
|
MA0112.3
|
ESR1 |
MCF7 (Invasive ductal breast carcinoma) |
E2 |
Permissive
Robust
|
Homo sapiens |
GSE60270
|
MA0112.3
|
ESR1 |
MCF7 (Invasive ductal breast carcinoma) |
SHCTR |
Permissive
Robust
|
Homo sapiens |
GSE60270
|
MA0112.3
|
ESR1 |
MCF7 (Invasive ductal breast carcinoma) |
SHCTR_E2 |
Permissive
Robust
|
Homo sapiens |
GSE60270
|
MA0112.3
|
ESR1 |
MCF7 (Invasive ductal breast carcinoma) |
SHFOXA1_E2 |
Permissive
Robust
|
Homo sapiens |
GSE60270
|
MA0112.3
|
ESR1 |
MCF7 (Invasive ductal breast carcinoma) |
SHGATA3_E2 |
Permissive
Robust
|
Homo sapiens |
GSE60270
|
MA0112.3
|
ESR1 |
MCF7 (Invasive ductal breast carcinoma) |
PROG |
Permissive
Robust
|
Homo sapiens |
GSE68355
|
MA0112.3
|
ESR1 |
MCF7 (Invasive ductal breast carcinoma) |
R5020 |
Permissive
Robust
|
Homo sapiens |
GSE68355
|
MA0112.3
|
ESR1 |
T47D (invasive ductal carcinoma) |
PROG |
Permissive
Robust
|
Homo sapiens |
GSE68355
|
MA0112.3
|
ESR1 |
T47D (invasive ductal carcinoma) |
R5020 |
Permissive
Robust
|
Homo sapiens |
GSE68355
|
MA0112.3
|
ESR1 |
MCF7 (Invasive ductal breast carcinoma) |
E2 |
Permissive
Robust
|
Homo sapiens |
GSE68356
|
MA0112.3
|
ESR1 |
MCF7 (Invasive ductal breast carcinoma) |
E2PG |
Permissive
Robust
|
Homo sapiens |
GSE68356
|
MA0112.3
|
ESR1 |
MCF7 (Invasive ductal breast carcinoma) |
E2 |
Permissive
Robust
|
Homo sapiens |
GSE71276
|
MA0112.3
|
ESR1 |
MCF7 (Invasive ductal breast carcinoma) |
E2 |
Permissive
Robust
|
Homo sapiens |
GSE72249
|
MA0112.3
|
ESR1 |
T47D (invasive ductal carcinoma) |
E2 |
Permissive
Robust
|
Homo sapiens |
GSE72249
|
MA0112.3
|
ESR1 |
ZR-75-1 (invasive ductal carcinoma) |
E2 |
Permissive
Robust
|
Homo sapiens |
GSE72249
|
MA0112.3
|
ESR1 |
MCF7 (Invasive ductal breast carcinoma) |
|
Permissive
Robust
|
Homo sapiens |
ERP000209
|
MA0112.3
|
ESR1 |
MCF7 (Invasive ductal breast carcinoma) |
|
Permissive
Robust
|
Homo sapiens |
ERP000380
|
MA0112.3
|
ESR1 |
MCF7 (Invasive ductal breast carcinoma) |
|
Permissive
|
Homo sapiens |
GSE54855
|
MA0112.3
|
ESR1 |
MCF7 (Invasive ductal breast carcinoma) |
|
Permissive
Robust
|
Homo sapiens |
GSE59530
|
MA0112.3
|
ESR1 |
MCF7 (Invasive ductal breast carcinoma) |
|
Permissive
Robust
|
Homo sapiens |
GSE60270
|
MA0112.3
|
ESR1 |
MCF7 (Invasive ductal breast carcinoma) |
|
Permissive
Robust
|
Homo sapiens |
GSE68355
|
MA0112.3
|
ESR1 |
T47D (invasive ductal carcinoma) |
|
Permissive
Robust
|
Homo sapiens |
GSE68355
|
MA0112.3
|
ESR1 |
MCF7 (Invasive ductal breast carcinoma) |
|
Permissive
|
Homo sapiens |
GSE68356
|
MA0112.3
|
ESR1 |
MCF7 (Invasive ductal breast carcinoma) |
|
Permissive
|
Homo sapiens |
GSE71276
|
MA0112.3
|
ESR1 |
MCF7 (Invasive ductal breast carcinoma) |
|
Permissive
Robust
|
Homo sapiens |
GSE72249
|
MA0112.3
|
ESR1 |
T47D (invasive ductal carcinoma) |
|
Permissive
Robust
|
Homo sapiens |
GSE72249
|
MA0112.3
|
ESR1 |
ZR-75-1 (invasive ductal carcinoma) |
|
Permissive
Robust
|
Homo sapiens |
GSE72249
|
MA0112.3
|